Clinical Trial Details
EORTC-40052
Back to Clinical Trials Database
Adjuvant treatment of fully resected stage III colon cancer with folfox-4 versus folfox-4 plus cetuximab (PETACC-8)
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 02-Jan-2006 Date Step1 close: 05-Nov-2009 |
| Data management at EORTC | No |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 150 - All Groups: 2000 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number | |
| EudraCT | 2005-003463-23 |
